Wendy's didn't just say no — it adopted a 'poison pill' defense to deter a hostile takeover. Here's why its board says Nelson Peltz's offer falls short.
Stanford geneticist Gary Peltz uses Co-Scientist to identify drug-repurposing candidates that could lead to new treatments for chronic liver disease and fibrosis